Therapeutic antibodies for COVID-19: is a new age of IgM, IgA and bispecific antibodies coming?
Early humoral immune responses to severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) are dominated by IgM and IgA antibodies, which greatly contribute to virus …
(SARS-CoV-2) are dominated by IgM and IgA antibodies, which greatly contribute to virus …
[PDF][PDF] Therapeutic antibodies for COVID-19: is a new age of IgM, IgA and bispecific antibodies coming?
J Zhang, H Zhang, L Sun - 2022 - researchgate.net
Early humoral immune responses to severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) are dominated by IgM and IgA antibodies, which greatly contribute to virus …
(SARS-CoV-2) are dominated by IgM and IgA antibodies, which greatly contribute to virus …
Therapeutic antibodies for COVID-19: is a new age of IgM, IgA and bispecific antibodies coming?
J Zhang, H Zhang, L Sun - mAbs, 2022 - pubmed.ncbi.nlm.nih.gov
Early humoral immune responses to severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) are dominated by IgM and IgA antibodies, which greatly contribute to virus …
(SARS-CoV-2) are dominated by IgM and IgA antibodies, which greatly contribute to virus …
Therapeutic antibodies for COVID-19: is a new age of IgM, IgA and bispecific antibodies coming?
J Zhang, H Zhang, L Sun - Mabs, 2022 - europepmc.org
Early humoral immune responses to severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) are dominated by IgM and IgA antibodies, which greatly contribute to virus …
(SARS-CoV-2) are dominated by IgM and IgA antibodies, which greatly contribute to virus …
[HTML][HTML] Therapeutic antibodies for COVID-19: is a new age of IgM, IgA and bispecific antibodies coming?
J Zhang, H Zhang, L Sun - mAbs, 2022 - ncbi.nlm.nih.gov
Early humoral immune responses to severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) are dominated by IgM and IgA antibodies, which greatly contribute to virus …
(SARS-CoV-2) are dominated by IgM and IgA antibodies, which greatly contribute to virus …
[PDF][PDF] Therapeutic antibodies for COVID-19: is a new age of IgM, IgA and bispecific antibodies coming?
J Zhang, H Zhang, L Sun - 2022 - scienceopen.com
Early humoral immune responses to severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) are dominated by IgM and IgA antibodies, which greatly contribute to virus …
(SARS-CoV-2) are dominated by IgM and IgA antibodies, which greatly contribute to virus …
[PDF][PDF] Therapeutic antibodies for COVID-19: is a new age of IgM, IgA and bispecific antibodies coming?
J Zhang, H Zhang, L Sun - 2022 - researchgate.net
Early humoral immune responses to severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) are dominated by IgM and IgA antibodies, which greatly contribute to virus …
(SARS-CoV-2) are dominated by IgM and IgA antibodies, which greatly contribute to virus …
Therapeutic antibodies for COVID-19: is a new age of IgM, IgA and bispecific antibodies coming?
J Zhang, H Zhang, L Sun - Mabs, 2022 - europepmc.org
Early humoral immune responses to severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) are dominated by IgM and IgA antibodies, which greatly contribute to virus …
(SARS-CoV-2) are dominated by IgM and IgA antibodies, which greatly contribute to virus …